[go: up one dir, main page]

ES447313A1 - Gonococcal pili processes for the preparation thereof and the use thereof - Google Patents

Gonococcal pili processes for the preparation thereof and the use thereof

Info

Publication number
ES447313A1
ES447313A1 ES447313A ES447313A ES447313A1 ES 447313 A1 ES447313 A1 ES 447313A1 ES 447313 A ES447313 A ES 447313A ES 447313 A ES447313 A ES 447313A ES 447313 A1 ES447313 A1 ES 447313A1
Authority
ES
Spain
Prior art keywords
pili
processes
preparation
gonococcal pili
gonococcal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES447313A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bactex Inc
Original Assignee
Bactex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bactex Inc filed Critical Bactex Inc
Publication of ES447313A1 publication Critical patent/ES447313A1/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/12—Nitrate to nitrite reducing bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Pili from Neisseria gonorrhoeae are prepared by the artificial cultivation of N. gonorrhoeae bacteria and processing of the culture to isolate the pili. The pili which are obtained are capable of forming antibodies in the organism and can be used for serological and immunological purposes. For diagnosis in vitro, the pili are brought into contact with the serum to be investigated in the absence of any cell residues.
ES447313A 1975-04-25 1976-04-23 Gonococcal pili processes for the preparation thereof and the use thereof Expired ES447313A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57120075A 1975-04-25 1975-04-25

Publications (1)

Publication Number Publication Date
ES447313A1 true ES447313A1 (en) 1977-10-16

Family

ID=24282722

Family Applications (1)

Application Number Title Priority Date Filing Date
ES447313A Expired ES447313A1 (en) 1975-04-25 1976-04-23 Gonococcal pili processes for the preparation thereof and the use thereof

Country Status (14)

Country Link
JP (1) JPS51130525A (en)
AU (1) AU509621B2 (en)
BE (1) BE841068A (en)
CA (1) CA1050423A (en)
CH (1) CH634923A5 (en)
DE (1) DE2617870A1 (en)
ES (1) ES447313A1 (en)
FR (1) FR2308377A1 (en)
GB (1) GB1549345A (en)
HU (1) HU174887B (en)
IE (1) IE44448B1 (en)
IL (1) IL49459A (en)
NL (1) NL7604311A (en)
ZA (1) ZA762438B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237115A (en) * 1977-11-23 1980-12-02 Bactex, Inc. Method of immunization against enterotoxogenic infection by Escherichia coli
US4203971A (en) * 1978-03-23 1980-05-20 Government Of The United States Neisseria gonorrhoeae vaccine
US4241045A (en) * 1978-05-15 1980-12-23 Research Corporation Purified antigen to test for Neisseria gonorrheae antibodies
EP0049945A3 (en) * 1980-09-15 1982-12-01 Bactex Incorporated Determining a hierarchy of piliated organisms and a vaccine prepared from such organisms
US4454117A (en) * 1980-09-15 1984-06-12 Bactex, Inc. Immunization against infection by Escherichia coli
DK219084D0 (en) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg ANTIGEN
US5132205A (en) * 1988-10-07 1992-07-21 Eastman Kodak Company High ph extraction composition and its use to determine a chlamydial, gonococcal or herpes antigen
GB9417880D0 (en) * 1994-09-06 1994-10-26 Auspharm Int Ltd Vaccine
EP1073748A2 (en) * 1998-04-29 2001-02-07 American Cyanamid Company Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951748A (en) * 1974-11-11 1976-04-20 Medical Products, Inc. Sensitized matrix for detection of disease

Also Published As

Publication number Publication date
IE44448L (en) 1976-10-25
IL49459A (en) 1980-02-29
DE2617870C2 (en) 1988-09-22
NL7604311A (en) 1976-10-27
AU1332176A (en) 1977-10-27
HU174887B (en) 1980-04-28
AU509621B2 (en) 1980-05-22
FR2308377B1 (en) 1979-04-06
ZA762438B (en) 1978-03-29
BE841068A (en) 1976-10-25
CH634923A5 (en) 1983-02-28
FR2308377A1 (en) 1976-11-19
JPS51130525A (en) 1976-11-12
CA1050423A (en) 1979-03-13
IL49459A0 (en) 1976-06-30
GB1549345A (en) 1979-08-08
IE44448B1 (en) 1981-12-02
JPH0118080B2 (en) 1989-04-03
DE2617870A1 (en) 1976-12-30

Similar Documents

Publication Publication Date Title
ES447313A1 (en) Gonococcal pili processes for the preparation thereof and the use thereof
Shinohara et al. Mitochondrialike structures in ultrathin sections of Mycobacterium avium
NL300020I2 (en) Production of virus antigens.
ATE7761T1 (en) VACCINE AND PRODUCTION PROCESS.
DE2964944D1 (en) A serological method for determining the presence of neisseria gonorrhoeae antibodies in human serum, a species-specific heat stable antigen to be used in this method and a method for the preparation of that antigen
GB1535063A (en) Process for preparing a curative agent for myelogenic leukemia
ES8307377A1 (en) Detection of human cancer cells with antibodies to human cancer cell nucleolar antigen(s)
JPS5231001A (en) Novel antibiotics-complex
ES424506A1 (en) Process for reducing sticking of blood cells to glass in blood testing procedures
CA1000221A (en) Process for the production of 1-malic acid by microbiological fermentation and means suitable for carrying out the same
ATE4327T1 (en) PROCEDURE FOR OBTAINING IMMUNOLOGICALLY ACTIVE ENZYME LABELED CONJUGATES.
SU122251A1 (en) Method of making associated vaccine concentrate against emphysematous carbuncle, malignant edema and cattle pasteurellosis
GB1522756A (en) Microbiological production of protein
ES438723A1 (en) Method of cultivating single-cell food proteins by a fermentation process
Hirano et al. Serological relationships between mycobacteria as determined by agar diffusion precipitation test
Ando et al. STUDIES ON THE EFFECT OF TWEEN 80 ON THE GROWTH OF ERYSIPELOTHRIX LNCIDIOSA
SU583107A1 (en) Method of heat treatment of cement raw mixture
FI51953C (en) A process for preparing a mixture for use as an inoculant in the manufacture of a dairy bacterial culture and fermented dairy products.
ROWE et al. Institut de Biochimie, Universit~ de Lausanne, 1011 Lausanne, Switzerland, and the Basle Institute for Immunology, CH-4058 Basle, Switzerland
AU488427B2 (en) Serological test for neisseria gonorrhoeae antibodies
McDaniels et al. Filter-passing bacteria in polluted water
AT339848B (en) FERMENTER FOR THE BREEDING OF MICROORGANISMS, IN PARTICULAR BAKING YEAST
AU5989273A (en) Serological test for neisseria gonorrhoeae antibodies
ES407704A1 (en) Procedure for the obtaining of proteins from ethanol synthesis. (Machine-translation by Google Translate, not legally binding)
Smirnova Serotyping strains of Pseudomonas aeruginosa